It is thus our opinion, as clinicians, scientists, and AKI experts, that novel biomarkers, such as NGAL and TIMP-2•IGFBP7, have considerable utility in the diagnosis and prognosis of AKI. The gene discussed is TIMP2; the disease is acute kidney injury.